Staten Island, NYNCT07092280Now EnrollingIRB Ready

Autism Spectrum Disorder Clinical Trial in Staten Island, NY

Access cutting-edge autism spectrum disorder treatment through this clinical trial at a research site in Staten Island. Study-provided care at no cost to qualified participants.

Sponsored by New York State Institute for Basic Research

Quick Self-Assessment

See if you qualify for this Staten Island location

Preparing your pre-screening questions…

Expert Care in Staten Island

Access autism spectrum disorder specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related autism spectrum disorder treatment provided free

Apply for This Staten Island Location

Check if you qualify for this autism spectrum disorder clinical trial in Staten Island, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Staten Island

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Staten Island site if eligible
  4. 4Begin participation

About This Autism Spectrum Disorder Study in Staten Island

Although many children diagnosed with autism spectrum disorder (ASD) make significant progress in learning and their cognitive skills improve with applied behavior analysis (ABA), there are a significant number of children who show an absence or a plateau in various skills. Deficits in executive functioning are likely to be involved in many of these cognitive and learning disabilities due to poor functioning of the prefrontal cortex. Currently, the use of biological methods for improving learning and cognition is largely unexplored in research and practice. The aim of this study is to use of transcranial direct current stimulation (tDCS) in combination with ABA to improve the acquisition of educational programs for students with ASD. tDCS is a low-level electrical neurostimulation and is most effective when used in combination with an active training or teaching, facilitating the neuronal circuits used for that task. tDCS has been used for various indications over a couple of decades and has been shown to be very safe and has been well-tolerated by children with ASD. The mechanism of tDCS is not clear, however animal studies show that tDCS can stimulate the flow of calcium ions through channels in the astrocytes, activating them, and facilitating their role in synapse formation and therefore learning.

Sponsor: New York State Institute for Basic Research

Who Can Participate

Inclusion Criteria

Males and females between 5 and 12 years with autism
Enrolled in an ABA program (school or in-home) supervised by a Board Certified Behavior Analyst (BCBA)
Stable medical and behavioral treatments for at least 4 weeks prior to, and during the study
Able to tolerate wearing tDCS as determined during a week-long daily desensitization training.

Exclusion Criteria

Any implanted metal device (heart pacemaker, cochlear implant, surgical clips, etc.)
Severe neurological disorders such as TBI, brain tumor, intracranial infection
Seizure disorder with a seizure within the last two years
Skull defect
Peripheral blindness or deafness
Medication that might affect tDCS: There have been a few studies concerning the effect of various medications on tDCS. Some may block and others may enhance the effects depending on many factors. The assay used to test these medications was its effect on the motor cortex after stimulation and this may not apply to our montages, however, in order to minimize the chances of having medication affect our results, participants taking the following medications will be excluded:
Na or Ca channel blockers which will include all anti-seizure medications
Medications that affect the NMDA receptors including dextromethorphan, cycloserine
Serotonin reuptake inhibitors
Dopamine stimulating or blocking medications including pergolide, bromocriptine and all antipsychotic medications
Norepinephrine stimulating or blocking agents including propranolol and the stimulants
Drugs that can lower seizure threshold \[imipramine, amitriptyline, doxepin, nortriptyline, maprotiline, chlorpromazine, clozapine, foscarnet, ganciclovir, ritonavir, amphetamines, phencyclidine, ketamine, gamma-hydroxybutyrate (GHB), alcohol, theophylline\]
Barbiturates, benzodiazepines, meprobamate, chloral hydrate in the past 4 weeks
Acute skin disease
History of magnetic or electrical stimulation

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Staten Island?

Yes, this clinical trial (NCT07092280) has an active research site in Staten Island, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Autism Spectrum Disorder Treatment Options in Staten Island, NY

If you're searching for autism spectrum disorder treatment options in Staten Island, NY, this clinical trial (NCT07092280) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Staten Island research site is actively enrolling participants for this clinical trial. You'll receive care from experienced autism spectrum disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all autism spectrum disorder clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Staten Island, NY

See all pulmonary embolism clinical trials recruiting in Staten Island — not just this study.

Browse Pulmonary Embolism Trials in Staten Island →

Ready to Join in Staten Island?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Staten Island, NY